Hyderabad-based Indian Immunologicals Limited (IIL) has partnered with Australia’s Griffith University to develop the COVID-19 vaccine. Scientists from IIL and Griffith University will jointly develop a “live attenuated SARS – CoV-2 vaccine” or COVID-19 vaccine using the “latest codon de-optimization technology”.
Click Here To Get Test Series For SBI PO 2020
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization. Upon the completion of the research, the vaccine strain will be transferred to ILL. It will work with the Central Drugs Standard Control Organisation (CDSCO), to conduct clinical trials. IIL intends to use its Vero cell platform tech for mass production of the vaccine.
What is Indian Immunologicals Limited?
Indian Immunologicals Limited is a major player in the human vaccine market in the country, supplying human pediatric and rabies vaccines. IIL is also a major supplier of pediatric vaccines to the country’s state-run universal immunization programme. IIL is promoted by the National Dairy Development Board. It is committed to addressing critical public health needs by engaging in this collaboration.
Important takeaways for all competitive exams:
The Daily Current Affairs Quiz which keeps you updated with the current events happening all…
The Tata Group is one of India's biggest and oldest business groups, known for its…
Nikita Porwal from Madhya Pradesh has emerged as the winner of the Femina Miss India…
NITI Aayog is gearing up to host the Second International Methanol Seminar and Expo 2024…
India’s Akhil Sheoran clinched the bronze medal in the 50m Rifle 3 Positions event at…
India is a land of diverse cities, each with its unique charm and identity. Many…